| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Transplantation and Cardiac Surgical Divisions,
*
Department of Surgery and
Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114
Progressive arterial stenosis (cardiac allograft vasculopathy (CAV)) is a leading cause of long-term failure of organ transplants. CAV remains intractable, in part because its mechanisms are insufficiently understood. A central proposition is that MHC-driven alloimmune processes play a necessary role in CAV, as shown by the absolute requirement for histoincompatibility between donor and recipient for its production. Two immunological pathways have been implicated involving reactivity to donor MHC Ags by either T or B cells. In this study, we use a novel system of semiallogeneic cardiac transplants between parental donors and F1 hybrid recipients to provide evidence that NK cells, members of the innate immune system, also contribute to the generation of CAV in mice. This finding marks the first demonstration that the hybrid resistance phenomenon occurs in solid organ allografts. Extension of these experiments to recipients deficient in T cells demonstrates that this third pathway of CAV, the NK cell-triggered pathway, involves the recruitment of T cells not responsive to donor alloantigens. Finally, transplants performed with donors or recipients deficient in IFN-
revealed that recipient-derived IFN- is necessary for CAV formation in parental to F1 transplants, suggesting a possible effector mechanism by which NK cells can promote CAV. Together, these results define a previously unknown pathway toward CAV and assign a novel role to NK cells in organ allograft rejection.
Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  T. S. Win, S. Rehakova, M. C. Negus, K. Saeb-Parsy, M. Goddard, T. M. Conlon, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew Donor CD4 T Cells Contribute to Cardiac Allograft Vasculopathy by Providing Help for Autoantibody Production Circ Heart Fail, July 1, 2009; 2(4): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hasegawa, D. Bouis, H. Liao, S. H. Visovatti, and D. J. Pinsky Ecto-5' Nucleotidase (CD73)-Mediated Adenosine Generation and Signaling in Murine Cardiac Allograft Vasculopathy Circ. Res., December 5, 2008; 103(12): 1410 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ito, H. Shimura, A. Nitahara, K. Tomiyama, M. Ito, T. Kanekura, K. Okumura, H. Yagita, and K. Kawai NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway Int. Immunol., October 1, 2008; 20(10): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Laffont, C. Seillet, J. Ortaldo, J. D. Coudert, and J.-C. Guery Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells Blood, August 1, 2008; 112(3): 661 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Beilke and R. G. Gill Frontiers in Nephrology: The Varied Faces of Natural Killer Cells in Transplantation Contributions to Both Allograft Immunity and Tolerance J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2262 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tellides and J. S. Pober Interferon-{gamma} Axis in Graft Arteriosclerosis Circ. Res., March 16, 2007; 100(5): 622 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yu, X. Xu, M. D. Vu, E. D. Kilpatrick, and X. C. Li NK cells promote transplant tolerance by killing donor antigen-presenting cells J. Exp. Med., August 7, 2006; 203(8): 1851 - 1858. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
